VITATOPS

VITATOPS

Vascular disease A study–Vitamins To Prevent Stroke designed to determine whether vitamins prevent stroke
Mentioned in ?
References in periodicals archive ?
The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial.
Hankey of Royal Perth (Australia) Hospital and his colleagues from the VITATOPS Trial Study Group reported.
The VITATOPS trial indicated that there is still weak evidence for a small relative risk reduction in fatal or nonfatal stroke with B vitamin supplementation.
In the VITATOPS trial, 8164 patients with a recent stroke or transient ischemic attack were -randomly assigned to receive, in double-blind fashion, placebo or daily B vitamins (2 mg of folic acid, 25 mg vitamin B6, and 500 mcg vitamin B12) and were followed up for a median 3.
Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo- control led trial, Lancet Neurol.